USA |OTCGREY |USD
|Public Float||P/E Ratio||-|
|% Short of Float||-||Dividend (Yield)||-|
|Held by Insiders||15.23%||Ex-Dividend Date|
|Held by Institutions||18.85%||IPO Date||-|
|Dec 19||Dec 18||Dec 17|
|Sep 20||Jun 20||Mar 20|
Alligator bioscience trades on the OTC Markets stock market in USA under the ticker symbol "ALLGF". Alligator bioscience’s stock symbol can also be displayed as "OTCMKTS:ALLGF".
Alligator bioscience (OTCMKTS:ALLGF) is owned by 18.85% institutional shareholders and by 15.23% insiders. The rest is owned by the public.
Explore More Details on Alligator bioscience's “Ownership” Section
Alligator bioscience's key executive team includes the following managers:
Alligator bioscience (OTCMKTS:ALLGF) is classified under the "" sector and under the "" industry.
Currently the number of employees working for Alligator bioscience is 46.
Alligator bioscience (OTCMKTS:ALLGF) is headquartered in Sweden.
Alligator bioscience’s mailing address is Medicon Village, Lund, Sweden, 223 81.
The company’s phone number is 46 4 65 40 82 00.